Loading...
SVE
ENG
About Us
About Us
Close
InDex Pharmaceuticals in brief
CEO corner
Corporate governance
General meetings
Nomination committee
Board of directors
Work of the board of directors
Management
Remuneration and incentive programmes
Auditors
Articles of association
Advisory Board North America
Advisory Board Europe
Investors
Investors
Close
The share
Dividend and dividend policy
Shareholders
InDex Pharmaceuticals on Nasdaq First North Growth Market
Financial reports
Presentations
Press releases
Subscribe
Financial calendar
Analysts
Prospectus archive
Certified Adviser
IR contact
Media
Media
Close
Press releases
Image bank
Subscribe
Media contact
Contact
Contact
Close
IR contact
Media contact
Certified Adviser
Search for:
About Us
InDex Pharmaceuticals in brief
CEO corner
Corporate governance
General meetings
Nomination committee
Board of directors
Work of the board of directors
Management
Remuneration and incentive programmes
Auditors
Articles of association
Advisory Board North America
Advisory Board Europe
Investors
The share
Dividend and dividend policy
Shareholders
InDex Pharmaceuticals on Nasdaq First North Growth Market
Financial reports
Presentations
Press releases
Subscribe
Financial calendar
Analysts
Prospectus archive
Certified Adviser
IR contact
Media
Press releases
Image bank
Subscribe
Media contact
Contact
IR contact
Media contact
Certified Adviser
Search for:
February 20, 2020
CEO interview on the conclusions from the in-depth analysis of the CONDUCT study